HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan Blay Selected Research

Mastocytoma

3/2003Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody.
5/2002Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan Blay Research Topics

Disease

24Neoplasms (Cancer)
12/2022 - 05/2002
11Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2003
10Neoplasm Metastasis (Metastasis)
01/2022 - 07/2004
7Carcinoma (Carcinomatosis)
01/2022 - 09/2003
4Breast Neoplasms (Breast Cancer)
06/2008 - 03/2002
4Hypoxia (Hypoxemia)
01/2008 - 11/2003
3Colonic Neoplasms (Colon Cancer)
11/2015 - 05/2002
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2013 - 12/2005
2Carcinogenesis
05/2007 - 09/2006
2Mastocytoma
03/2003 - 05/2002
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2021
1Leukemia
01/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1Inflammation (Inflammations)
01/2008
1Disease Progression
01/2008
1Adenocarcinoma
12/2007
1Shock
07/2007
1Rectal Neoplasms (Rectal Cancer)
05/2007
1Type 2 Diabetes Mellitus (MODY)
05/2007
1Lymphoma (Lymphomas)
03/2003
1Apnea
05/2002

Drug/Important Bio-Agent (IBA)

9Adenosine (Adenocard)FDA LinkGeneric
03/2008 - 05/2002
6Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2004
5Purine NucleosidesIBA
03/2008 - 05/2002
4ApigeninIBA
01/2022 - 04/2011
4Chemokine ReceptorsIBA
11/2015 - 11/2006
3flavoneIBA
01/2022 - 04/2011
3LigandsIBA
01/2022 - 03/2002
3Fluorouracil (Carac)FDA LinkGeneric
11/2015 - 09/2003
3ChemokinesIBA
01/2013 - 07/2004
3PPAR gammaIBA
01/2008 - 05/2007
2Irinotecan (Camptosar)FDA LinkGeneric
11/2015 - 04/2011
2Chemokine CXCL12IBA
11/2015 - 11/2006
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2015 - 04/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
04/2011 - 09/2006
2Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2008 - 11/2006
2NucleosidesIBA
01/2008 - 05/2002
2EicosanoidsIBA
01/2008 - 10/2007
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
09/2006 - 07/2004
2DNA (Deoxyribonucleic Acid)IBA
12/2004 - 11/2003
1AntiemeticsIBA
12/2022
1CannabinoidsIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Therapeutic UsesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Mitochondrial DNA (mtDNA)IBA
01/2019
110-N-nonylacridinium orange (NAO)IBA
01/2019
1Rhodamine 123IBA
01/2019
1dihydroethidiumIBA
01/2019
1Acridine OrangeIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Immunoconjugates (Immunoconjugate)IBA
12/2017
1Peptide Hydrolases (Proteases)FDA Link
11/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Cell Adhesion MoleculesIBA
01/2013
1FlavonoidsIBA
04/2011
1EnzymesIBA
04/2011
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
04/2011
1Adenosine DeaminaseIBA
04/2011
1Ether (Diethyl Ether)IBA
06/2008
1Potassium Channels (Potassium Channel)IBA
06/2008
1AstemizoleIBA
06/2008
1Imipramine (Janimine)FDA LinkGeneric
06/2008
1Cancer VaccinesIBA
03/2008
1Peptides (Polypeptides)IBA
01/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2007
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2007
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2007
1CXCR4 Receptors (CXCR4 Receptor)IBA
10/2007
1ProstaglandinsIBA
10/2007
1Prostaglandins AIBA
10/2007
1Prostaglandins DIBA
10/2007
1Prostaglandins EIBA
10/2007
1CarbonIBA
07/2007
1Ethanol (Ethyl Alcohol)IBA
07/2007
12,4-thiazolidinedione (thiazolidinedione)IBA
05/2007
1Rosiglitazone (Avandia)FDA Link
05/2007
1Messenger RNA (mRNA)IBA
11/2006
1Protein Tyrosine PhosphatasesIBA
09/2006
1Transforming Growth Factor beta (TGF-beta)IBA
12/2005
1ThymidineIBA
12/2004
1GuanosineIBA
07/2004
1InosineFDA Link
07/2004
1CeramidesIBA
09/2003
1Cisplatin (Platino)FDA LinkGeneric
09/2003
1Paclitaxel (Taxol)FDA LinkGeneric
03/2003
1Vinblastine (Vinblastine Sulfate)FDA Link
03/2003
1Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA
05/2002
1integrin alpha4beta7IBA
05/2002
1IntegrinsIBA
05/2002
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
05/2002
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2002
1Integrin alpha5beta1IBA
05/2002
1AntibodiesIBA
05/2002
1fas Receptor (CD95 Antigen)IBA
03/2002
1Death Domain ReceptorsIBA
03/2002
1Fas Ligand Protein (Fas Ligand)IBA
03/2002

Therapy/Procedure

4Therapeutics
01/2022 - 01/2008
3Drug Therapy (Chemotherapy)
12/2022 - 03/2002
2Immunotherapy
03/2008 - 03/2002